Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000102909-26-000302·ROCKET PHARMACEUTICALS, INC.
Schedule 13G ownership disclosure
Rocket Pharmaceuticals Inc
Common Stock · CUSIP: 77313F106
Event date: 2025-12-31
- Filing-level shares
- 8,544,423
- Percent of class
- 7.89%
- The Vanguard Group
Shares: 8,544,423 · Class: 7.89%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-26-000302
- Form type
- SCHEDULE 13G/A
- Filer
- ROCKET PHARMACEUTICALS, INC.
- CIK
- CIK 1281895
- Filed
- Jan 30, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership